Zobrazeno 1 - 10
of 316
pro vyhledávání: '"Jaap A. Joles"'
Autor:
Suvanjaa Sivalingam, Emil List Larsen, Daniel H. van Raalte, Marcel H. A. Muskiet, Mark M. Smits, Lennart Tonneijck, Jaap A. Joles, Bernt Johan von Scholten, Emilie Hein Zobel, Frederik Persson, Trine Henriksen, Lars Jorge Diaz, Tine W. Hansen, Henrik Enghusen Poulsen, Peter Rossing
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor ag
Externí odkaz:
https://doaj.org/article/3bcc699d77684b339336dcb21eb97295
Autor:
Joost C. de Vries, Maaike K. van Gelder, Anneke S. Monninkhof, Sabbir Ahmed, Diënty H. M. Hazenbrink, Tri Q. Nguyen, Gèrard A. P. de Kort, Evert-Jan P. A. Vonken, Koen R. D. Vaessen, Jaap A. Joles, Marianne C. Verhaar, Karin G. F. Gerritsen
Publikováno v:
Toxins, Vol 14, Iss 9, p 635 (2022)
With increasing interest in home dialysis, there is a need for a translational uremic large animal model to evaluate technical innovations in peritoneal dialysis (PD). To this end, we developed a porcine model with kidney failure. Stable chronic kidn
Externí odkaz:
https://doaj.org/article/aa5fadff8d85457a9da6eea6c7408896
Autor:
Marian Wesseling, Eva Mulder, Maike A. D. Brans, Daniek. M. C. Kapteijn, Marian Bulthuis, Gerard Pasterkamp, Marianne C. Verhaar, A. H. Jan Danser, Harry van Goor, Jaap A. Joles, Saskia C. A. de Jager
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Cardiorenal syndrome type 2 is characterized by kidney failure as a consequence of heart failure that affects >50% of heart failure patients. Murine transverse aortic constriction (TAC) is a heart failure model, where pressure overload is induced on
Externí odkaz:
https://doaj.org/article/dde3f13552ef4eaf8a4ce7838f13f152
Autor:
Isabel T. N. Nguyen, Lucas M. Wiggenhauser, Marian Bulthuis, Jan-Luuk Hillebrands, Martin Feelisch, Marianne C. Verhaar, Harry van Goor, Jaap A. Joles
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Hypertension contributes to cardiac damage and remodeling. Despite the availability of renin-angiotensin system inhibitors and other antihypertensive therapies, some patients still develop heart failure. Novel therapeutic approaches are required that
Externí odkaz:
https://doaj.org/article/c3560343d2ce44d38fd4de1b39e336e4
Autor:
Javier Egea, Isabel Fabregat, Yves M. Frapart, Pietro Ghezzi, Agnes Görlach, Thomas Kietzmann, Kateryna Kubaichuk, Ulla G. Knaus, Manuela G. Lopez, Gloria Olaso-Gonzalez, Andreas Petry, Rainer Schulz, Jose Vina, Paul Winyard, Kahina Abbas, Opeyemi S. Ademowo, Catarina B. Afonso, Ioanna Andreadou, Haike Antelmann, Fernando Antunes, Mutay Aslan, Markus M. Bachschmid, Rui M. Barbosa, Vsevolod Belousov, Carsten Berndt, David Bernlohr, Esther Bertrán, Alberto Bindoli, Serge P. Bottari, Paula M. Brito, Guia Carrara, Ana I. Casas, Afroditi Chatzi, Niki Chondrogianni, Marcus Conrad, Marcus S. Cooke, João G. Costa, Antonio Cuadrado, Pham My-Chan Dang, Barbara De Smet, Bilge Debelec–Butuner, Irundika H.K. Dias, Joe Dan Dunn, Amanda J. Edson, Mariam El Assar, Jamel El-Benna, Péter Ferdinandy, Ana S. Fernandes, Kari E. Fladmark, Ulrich Förstermann, Rashid Giniatullin, Zoltán Giricz, Anikó Görbe, Helen Griffiths, Vaclav Hampl, Alina Hanf, Jan Herget, Pablo Hernansanz-Agustín, Melanie Hillion, Jingjing Huang, Serap Ilikay, Pidder Jansen-Dürr, Vincent Jaquet, Jaap A. Joles, Balaraman Kalyanaraman, Danylo Kaminskyy, Mahsa Karbaschi, Marina Kleanthous, Lars-Oliver Klotz, Bato Korac, Kemal Sami Korkmaz, Rafal Koziel, Damir Kračun, Karl-Heinz Krause, Vladimír Křen, Thomas Krieg, João Laranjinha, Antigone Lazou, Huige Li, Antonio Martínez-Ruiz, Reiko Matsui, Gethin J. McBean, Stuart P. Meredith, Joris Messens, Verónica Miguel, Yuliya Mikhed, Irina Milisav, Lidija Milković, Antonio Miranda-Vizuete, Miloš Mojović, María Monsalve, Pierre-Alexis Mouthuy, John Mulvey, Thomas Münzel, Vladimir Muzykantov, Isabel T.N. Nguyen, Matthias Oelze, Nuno G. Oliveira, Carlos M. Palmeira, Nikoletta Papaevgeniou, Aleksandra Pavićević, Brandán Pedre, Fabienne Peyrot, Marios Phylactides, Gratiela G. Pircalabioru, Andrew R. Pitt, Henrik E. Poulsen, Ignacio Prieto, Maria Pia Rigobello, Natalia Robledinos-Antón, Leocadio Rodríguez-Mañas, Anabela P. Rolo, Francis Rousset, Tatjana Ruskovska, Nuno Saraiva, Shlomo Sasson, Katrin Schröder, Khrystyna Semen, Tamara Seredenina, Anastasia Shakirzyanova, Geoffrey L. Smith, Thierry Soldati, Bebiana C. Sousa, Corinne M. Spickett, Ana Stancic, Marie José Stasia, Holger Steinbrenner, Višnja Stepanić, Sebastian Steven, Kostas Tokatlidis, Erkan Tuncay, Belma Turan, Fulvio Ursini, Jan Vacek, Olga Vajnerova, Kateřina Valentová, Frank Van Breusegem, Lokman Varisli, Elizabeth A. Veal, A. Suha Yalçın, Olha Yelisyeyeva, Neven Žarković, Martina Zatloukalová, Jacek Zielonka, Rhian M. Touyz, Andreas Papapetropoulos, Tilman Grune, Santiago Lamas, Harald H.H.W. Schmidt, Fabio Di Lisa, Andreas Daiber
Publikováno v:
Redox Biology, Vol 13, Iss C, Pp 94-162 (2017)
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated t
Externí odkaz:
https://doaj.org/article/637c0e34ca5240b4924d5b20463b39fc
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-5 (2017)
Abstract Background The pathological condition of chronic kidney disease may not be adequately recapitulated in immunocompromised mice due to the lack of T-cells, which are important for the development of hypertension and renal injury. We studied th
Externí odkaz:
https://doaj.org/article/20f70f7705ac4a1a81b11980144e0874
Autor:
Jens van de Wouw, Michelle Broekhuizen, Oana Sorop, Jaap A. Joles, Marianne C. Verhaar, Dirk J. Duncker, A. H. Jan Danser, Daphne Merkus
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
Heart failure (HF) and chronic kidney disease (CKD) co-exist, and it is estimated that about 50% of HF patients suffer from CKD. Although studies have been performed on the association between CKD and HF with reduced ejection fraction (HFrEF), less i
Externí odkaz:
https://doaj.org/article/58abb98c8e1443a8bab58846cd3b1035
Autor:
Michele F. Eisenga, Mireille E. Emans, Karien van der Putten, Maarten J. Cramer, Adry Diepenbroek, Birgitta K. Velthuis, Pieter A. Doevendans, Marianne C. Verhaar, Jaap A. Joles, Stephan J. L. Bakker, Ilja M. Nolte, Branko Braam, Carlo A. J. M. Gaillard
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 16 (2019)
Background In patients with chronic heart failure and chronic kidney disease, correction of anemia with erythropoietin‐stimulating agents targeting normal hemoglobin levels is associated with an increased risk of cardiovascular morbidity and mortal
Externí odkaz:
https://doaj.org/article/baf6c377b3794abc9b1eaaa51c0774c2
Autor:
Michaël J. B. van Baar, Annemarie B. van der Aart, Klaas Hoogenberg, Jaap A. Joles, Hiddo J. L. Heerspink, Daniël H. van Raalte
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 10 (2019)
Diabetic kidney disease (DKD) remains the main cause for chronic kidney disease (CKD) and end-stage kidney disease (ESKD) worldwide. Both CKD and ESKD lead to major increases in risk of cardiovascular disease and death in people with diabetes. Despit
Externí odkaz:
https://doaj.org/article/08bc2749712c4e49b5cc81911af12549
Autor:
Maaike K. van Gelder, Jasper Stevens, Tobias T. Pieters, Koen R. D. Vaessen, Jaap A. Joles, Marianne C. Verhaar, Karin G. F. Gerritsen
Publikováno v:
Biology, Vol 10, Iss 6, p 461 (2021)
The preclinical evaluation of novel therapies for chronic kidney disease requires a simple method for the assessment of kidney function in a uremic large animal model. An intravenous bolus of iohexol was administered to goats (13 measurements in n =
Externí odkaz:
https://doaj.org/article/38f7e1745b584b3a8fc55b0e80e49aa8